市场调查报告书
商品编码
1518340
蛋白质表现市场:按系统、提供、应用、最终用户划分 -2030年全球预测Protein Expression Market by System (Mammalian, Non-mammalian ), Offering (Kits & Reagents, Vectors, Competent Cells, Services), Application (Industrial, Therapeutic, Research), and End User - Global Forecast to 2030 |
到2030年,蛋白质表现市场预计将达到 50 亿美元,2023年至2030年年复合成长率为 7.6%。
经过广泛的二次和初步研究以及对市场情景的详细分析,本报告对关键行业驱动因素、限制因素、机会和挑战进行了分析。
生物製药市场的成长、对重组蛋白的需求不断增加、政府支持措施以及生命科学研究资金推动该市场的成长。然而,基于蛋白质的研究成本高昂,且缺乏熟练的专业人员,限制了该市场的成长。此外,新兴国家预计将为蛋白质表现市场的公司提供巨大的成长机会。然而,实验室转化参数的复杂性构成了限制市场成长的挑战。
(註:预计提供前 5 名公司的 SWOT 分析)
Protein Expression Market Size, Share, Forecast, & Trends Analysis by System (Mammalian [CHO, HEK 293], Non-mammalian [Bacterial, Insect]), Offering (Kits & Reagents, Competent Cells, Services), Application, and End User - Global Forecast to 2030
The protein expression market is projected to reach $5 billion by 2030 at a CAGR of 7.6% from 2023 to 2030.
Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges.
The growing biopharmaceutical market, the rising demand for recombinant proteins, supportive government initiatives, and funding for life science research are driving the growth of this market. However, the high costs of protein-based research and the lack of skilled professionals restrain the growth of this market. Furthermore, emerging economies are expected to offer significant growth opportunities for players operating in the protein expression market. However, complexities in laboratory transformation parameters are a challenge limiting market growth.
The report offers a competitive landscape based on an extensive assessment of the product portfolios, geographic presence, and key strategic developments of leading market players during the last four years (2020-2023). The key players operating in the protein expression market are Thermo Fisher Scientific Inc. (U.S.), Promega Corporation (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Takara Holdings Inc. (Japan), GenScript Biotech Corporation (U.S.), Qiagen N.V. (Germany), Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), and Becton, Dickinson and Company (U.S.).
Based on system, in 2023, the Chinese Hamster Ovary (CHO) cell line segment is expected to account for the largest share of the mammalian protein expression market. The large market share of this segment is attributed to the popularity of CHO cell lines in the production of biologics, the high similarity of CHO cells to the human cell system, and the high reproducibility of CHO cells.
Based on offering, the services segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is driven by the increasing outsourcing of operations by pharma & biotech companies, the rising demand for biopharmaceuticals, collaborations between industry and academia for rapid bioproduction, and the growing demand for recombinant proteins in the non-healthcare sector.
Based on application, in 2023, the therapeutic segment is estimated to account for the largest share of the protein expression market. The large market share of this segment is attributed to the increasing incidence of diseases requiring therapeutic approaches for treatment and growth in R&D for therapeutic protein production.
Based on end user, in 2023, the contract research organizations segment is estimated to account for the largest share of the protein expression market. The large market share of this segment can be attributed to the increase in research activities and growth in outsourcing for the development of biologics.
An in-depth analysis of the geographical scenario in the protein expression market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the protein expression market. Furthermore, in 2023, the U.S. is expected to account for the major share of the protein expression market in North America. The large share of this market is primarily attributed to the presence of key market players, growth in R&D activities, and the significant volume of bioproduction.
Protein Expression Market Assessment-by System
Note: Other mammalian cell lines include baby hamster kidney cells, non-secreting murine myeloma cells, and PER.C6.
Protein Expression Market Assessment-by Offering
Protein Expression Market Assessment-by Application
Protein Expression Market Assessment-by End User
Protein Expression Market Assessment-by Geography
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)